Revolution Medicines, Inc. — Form D
Revolution Medicines, Inc. of Redwood City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-10. The offering totals $56.4M, of which $56.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-07-10
- Form: D
- Accession: 0001140361-18-032012
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $56.4M
- Amount sold: $56.4M
- Investors: 18
- Date of first sale: 2018-03-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-316399
Issuer
- Name: Revolution Medicines, Inc.
- CIK: 0001628171
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 700 Saginaw Dr, Redwood City, CA, 94063
- Phone: 650-481-6808
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Ryan A Martins | Executive Officer | Redwood City, CA |
| Luan A Wilfong | Executive Officer | Redwood City, CA |
| Alexis A Borisy | Director | CAMBRIDGE, MA |
| Neil A Exter | Director | Boston, MA |
| Barbara A Weber | Director | Redwood City, CA |
| Thilo A Schroeder | Director | Redwood City, CA |
| Vincent A Miller | Director | Redwood City, CA |
| Laurence A Lasky | Director | Redwood City, CA |
| Mark A Goldsmith | Director | Redwood City, CA |
| Mark A Goldsmith | Executive Officer | Redwood City, CA |
| Margaret A Horn | Executive Officer | Redwood City, CA |
| Elizabeth A Anderson | Director | Redwood City, CA |
| Steve A Kelsey | Executive Officer | Redwood City, CA |
| Michael A Bonney | Director | Redwood City, CA |
Other filings by this issuer (2)
More